EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale

Samuel A Kareff iD, Virginia Corbett, Paul Hallenbeck, Aman Chauhan

Cells · 2023

DOI: 10.3390/cells12222623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Samuel A Kareff und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Receptors, Cell Surface, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TEM8 protein represents an emerging biomarker in many solid tumor histologies. Given the various roles it plays in oncogenesis, including but not limited to angiogenesis, epithelial-to-mesenchymal transition, and cell migration, TEM8 has recently served and will continue to serve as the target of novel oncologic therapies. We review herein the role of TEM8 in oncogenesis. We review its normal function, highlight the additional roles it plays in the tumor microenvironment, and synthesize pre-clinical and clinical data currently available. We underline the protein’s prognostic and predictive abilities in various solid tumors by (1) highlighting its association with more aggressive disease biology and poor clinical outcomes and (2) assessing its associated clinical trial landscape. Finally, we offer future directions for clinical studies involving TEM8, including incorporating pre-clinical agents into clinical trials and combining previously tested oncologic therapies with currently available treatments, such as immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Cell SurfaceNeoplasmsHumansNeoplasm ProteinsMicrofilament ProteinsCell Transformation, NeoplasticCarcinogenesisBiologyTumor Microenvironment

Stichwörter der Autor:innen

ANTXR1TEM8oncogenesis

Substanzen

Receptors, Cell SurfaceNeoplasm ProteinsMicrofilament Proteins

Autor:innen und Institutionen

  • University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33136, USA.
  • Mount Sinai Tisch Cancer Center, New York, NY 10029, USA.
  • Seneca Therapeutics, Philadelphia, PA 19103, USA.
  • Division of Medical Oncology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.

ORCID-Profile: Samuel A Kareff

Zitieren

APA

Kareff, S. A., Corbett, V., Hallenbeck, P., & Chauhan, A. (2023). TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale. Cells. https://doi.org/10.3390/cells12222623

Vancouver

Kareff SA, Corbett V, Hallenbeck P, Chauhan A. TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale. Cells. 2023. doi:10.3390/cells12222623

BibTeX
@article{Kareff2023,
  author = {Kareff, Samuel A and Corbett, Virginia and Hallenbeck, Paul and Chauhan, Aman},
  title = {TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12222623}
}
Kostenlos starten →